Mares Ltd. was founded by Christian van den Bos in 2007 to serve the biotech- and pharmaceutical industry. He serves as ist director.
Previously, he experienced as international R&D Manager, he has been actively developing and up-scaling ATMPs for more than 20 years, including 10 years of US-based professional activities. He served in responsible scientific and managerial positions at Lonza (Germany), Cytograft (USA), Symetis (Switzerland, Germany), ViaCell (USA), Kourion (Germany), Spectra Stable Isotopes (USA), Martek Biosciences (USA) and Osiris Therapeutics (USA). Christian enjoyed post-doctoral training at Cold Spring Harbor Laboratories (USA), obtained a Ph.D. from the University of Muenster (Germany), and a degree of Master of Science from the university of Oxford (UK).
In his career, Christian contributed to all stages of drug development – from early research to commercial manufacturing. His recent track record includes:
Christian van den Bos has been recognized as a Qualified Person (QP) for ATMPs according to EU requirements.
Mares Ltd. is registered in England & Wales
Phone: +49 2571 9588001
Fax: +49 2571 9588003
E-Mail: contact @maresltd.eu
Director / Geschäftsführer: Dr. rer. nat. R. Christian van den Bos, M.Sc. (Oxon)